Esther Fasanmi
Fort Worth
Summary
Clinical Pharmacist with nearly a decade of experience at a large integrated health system, bringing a strong foundation in evidence-based pharmacotherapy, cross-functional collaboration, and real-world data evaluation. Proven contributor to outcomes research, with peer-reviewed publications in HIV and viral hepatitis. Experienced in translating clinical evidence into clear, actionable insights for diverse stakeholders, including clinicians and healthcare leadership.
Overview
10
10
years of professional experience
1
1
Certification
Work History
Consultant
RTI International
12.2025 - Current
- Consultant to RTI International on the Data Analytics and Program Support for Implementation of the Medicare Drug Provisions of the Inflation Reduction Act (IRA) Project (2026).
- Provides expert consultation on specific conditions and treatments that may inform CMS drug price negotiations under the Inflation Reduction Act.
Clinical Pharmacist – Ambulatory (HIV/Hepatitis C)
John Peter Smith (JPS) Health Network
Fort Worth, Texas
08.2016 - Current
- Provide comprehensive medication therapy management for diverse patient populations under a robust collaborative practice agreement, optimizing pharmacotherapy outcomes and minimizing adverse events.
- Collaborate with interdisciplinary healthcare teams to develop and implement evidence-based treatment plans, ensuring high-quality, patient-centered care.
- Educate healthcare professionals and patients on disease states, medication regimens, and emerging therapies, translating complex clinical data into actionable insights.
- Conduct clinical research and quality improvement initiatives, contributing to published studies on antiviral therapies and chronic disease management.
- Lead and participate in clinical preventive services, including patient screenings, immunizations, and health education, to improve population health outcomes.
- Serve as an expert resource for drug information, formulary management, and therapeutic guideline development, supporting safe and effective medication use across the health system.
Clinical Adjunct Professor
University of North Texas Health Science Center – College of Pharmacy
08.2016 - Current
- Develop and deliver comprehensive lectures on pathophysiology, diagnosis, and management of viral hepatitis to pharmacy students.
- Integrate current clinical guidelines and recent research findings into educational content, emphasizing evidence-based approaches to hepatitis treatment.
- Facilitate interactive case discussions and problem-based learning sessions to enhance students’ clinical reasoning and decision-making skills.
Education
Master of Science - Pharmacy
Texas Southern University, College of Pharmacy And Health Sciences
Houston, Texas05-2014
Pre-Pharmacy Coursework - undefined
Texas Southern University
Houston, Texas01-2010
Skills
- Therapeutic area expertise
- Critical appraisal of clinical trials and real-world evidence
- Scientific exchange with healthcare professionals
- High-level scientific presentation skills
- Cross-functional collaboration
- Advisory board participation
Affiliations
- American Association for the Study of Liver Diseases 2021 – present
- Society of Infectious Diseases Pharmacists 2015 – present
- American College of Clinical Pharmacy 2014 – present
- American Academy of HIV Medicine 2013 – present
- Phi Lambda Sigma – Pharmacy Leadership Society 2013 – present
- The Rho Chi Society – The Academic Honor Society in Pharmacy 2013 – present
- Delta Theta Chapter, Kappa Psi Pharmaceutical Fraternity, Incorporated 2012 – present
Certification
- Oklahoma Licensed Pharmacist Oklahoma State Board of Pharmacy July 2015
- Texas Licensed Pharmacist Texas State Board of Pharmacy August 2014
- Louisiana Licensed Pharmacist Louisiana Board of Pharmacy July 2014
- Board Certified Infectious Diseases Pharmacist Board of Pharmacy Specialties July 2019
- Basic Life Support for Providers American Heart Association June 2017
- HIV Pharmacist (AAHIVP) American Academy of HIV Medicine January 2017
- Texas Licensed Pharmacy Preceptor Texas State Board of Pharmacy July 2016
- Board Certified Pharmacotherapy Specialist Board of Pharmacy Specialties December 2015
- Oklahoma Licensed Pharmacy Preceptor Oklahoma State Board of Pharmacy September 2015
- HIV Prevention Counselor and Rapid Testing Provider Louisiana Office of Public Health May 2015
- Pharmacy-Based Immunization Delivery American Pharmacists Association April 2013
- Sterile Products/Aseptic Technique Program National Intravenous Training Program for Pharmacists June 2012
Timeline
Consultant
RTI International
12.2025 - Current
Clinical Pharmacist – Ambulatory (HIV/Hepatitis C)
John Peter Smith (JPS) Health Network
08.2016 - Current
Clinical Adjunct Professor
University of North Texas Health Science Center – College of Pharmacy
08.2016 - Current
Pre-Pharmacy Coursework - undefined
Texas Southern University
Master of Science - Pharmacy
Texas Southern University, College of Pharmacy And Health Sciences
COMMITTEE INVOLVEMENT
- Texas Chapter Committee Member American Academy of HIV Medicine 2025 – present
- Hepatology Associates Committee (sole pharmacist member) American Association for the Study of Liver Diseases 2023 – 2025
- Healing Wings Ryan White Quality Committee JPS Health Network 2023 – present
- Local AIDS Pharmaceutical Assistance Formulary Committee Ryan White Administrative Agency, Tarrant County 2021 – present
- GI/Liver/Nutrition PRN Committee Member American College of Clinical Pharmacy 2020 – present
- Ending the HIV Epidemic Taskforce Tarrant County Public Health Department 2020 – 2022
- HIV Clinical Panel (sole pharmacist member) Texas Department of State Health Services 2019 – 2020
- Pharmacists Committee American Academy of HIV Medicine 2018 – 2023
- Membership Committee Society of Infectious Diseases Pharmacists 2016 – 2022
- Affiliated Faculty Member (HIV and Hepatitis C Working Groups) JPS Health Network Center for Outcomes Research 2016 – present
- Antimicrobial Utilization Committee – Outpatient Subcommittee Chair JPS Health Network 2016 – 2020
- HIV PRN Committee Member American College of Clinical Pharmacy 2015 – present
SCHOLARSHIPS AND AWARDS
- JPS Health Network Sunflower Award June 2024 JPS Ambassador January 2021
- Ethel Ransom Humanitarian & Cultural Club The Outstanding Medical Professional as a Pharmacist April 2023
- Warren E. Weaver/Richard P. Penna Award Board of Pharmacy Specialties March 2023
- Texas Southern University College of Pharmacy and Health Sciences Mylan Institute of Pharmacy Excellence in Pharmacy Award May 2014 Excellence in Achievement Award May 2014
- Graduating Senior Educational Grant Award May 2014 Kappa Psi Pharmaceutical Fraternity Incorporated, Scholarship Certificate October 2013 Pre-Pharmacy Scholar Award May 2009
- Texas Southern University National Society of Collegiate Scholars 2009 – 2014 Thomas Freeman Honors College Scholar 2008 – 2014
TEACHING EXPERIENCES
- JPS Health Network Family Medicine Residency Program HCV in Primary Care Nurse Practitioner and Family Medicine Residency Program HIV Prevention and Treatment (2 hour lecture) Family Medicine Residency Program Antimicrobial Stewardship In Primary Care: Not Just an Inpatient Issue. (2 hour lecture) Spring 2024
- Continuing Education for Pharmacists Out with the Old in with the New: An Update on HIV Pharmacotherapy What Happens When $100,000 Worth of Treatment Fails? – Retreatment Options for Hepatitis C Virus Spring 2017
- University of North Texas College of Pharmacy PHAR 7321: Pharmacology of Infectious Diseases Antivirals – Hepatitis B and C (2-hour lecture) Fall 2022 – present PHAR 7451: Infectious Diseases Viral Hepatitis (2-hour lecture) Fall 2018 – present
- University of Oklahoma College of Pharmacy PHAR 7970: Seminar Pharmacy Practice Co-Facilitator Spring 2016 PHAR 7323: Pharmacy Practice VI Patient Counseling; Lab Evaluator (4 sessions) PHAR 7124: Pharmacy Practice II Herbal and Complementary Medicine (1-hour lecture) PHAR 7873: Pharmaceutical Care VII Antimycobacterials and Tuberculosis (2-hour lecture) Fall 2015 PHAR 7813: Pharmaceutical Care I Health Module; Small Group Facilitator (4 sessions)
- Xavier University of Louisiana College of Pharmacy PCLN 4680: Disease State Management III Lower Respiratory Tract Infections; Team-Based Learning Facilitator (2.5 hours) Summer 2015 PHCY 4042L: Pharmacy Skills Laboratory II Gastrointestinal Disorders; Lab Instructor (4 sessions) Fall 2014
PRESENTATIONS
- The Expanding Role of Advanced Practice Providers in Hepatology: A Collaborative Approach to Liver Care Panelist presenter at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting Audience: Physicians, Advanced Practice Providers, Pharmacists November 2025
- Innovative Strategies on the Use of Long-Acting Antiretroviral Therapy Platform Presentation at the AETC South Central BeU Symposium Audience: Physicians, Advanced Practice Providers, Pharmacists, Case Managers, Community Health Workers February 2025
- APPs as Leaders in HCV Elimination Programs Panelist presenter at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting Audience: Physicians, Advanced Practice Providers, Pharmacists November 2024
- Management of Hepatitis C in a County Jail Webinar-based presentation through Project ECHO Audience: Physicians, Advanced Practice Providers, Pharmacists, Case Managers, Community Health Workers July 2024
- You're My, My, My, My, Liver: Hepatitis C Update Platform presentation at the American Pharmacists Association (APhA) 2024 Meeting Audience: Pharmacists, Pharmacy Residents and Pharmacy Students March 2024
- Access to Drug: Rapid Start Webinar-based presentation through South Central AIDS Education and Training Center (SCAETC)/University of Texas Medical Branch 4th Annual Conference Audience: Physicians, Advanced Practice Providers, Pharmacists, Nurses April 2020
- DHHS HIV Treatment Guidelines Update Webinar-based presentation through the Texas Department of State Health Services Audience: Physicians, Advanced Practice Providers, Pharmacists, Nurses December 2019
- ART Initiation and Common Drug-Drug Interactions Webinar-based presentation through South Central AIDS Education and Training Center (SCAETC) Audience: Correctional Health Physicians and Advanced Practice Providers February 2019
- Adherence Thresholds for Viral Suppression in HIV-Infected Patients Platform presentation at the University of Oklahoma’s Infectious Disease Conference Audience: Pharmacists, Infectious Diseases Physicians, Infectious Diseases Fellows June 2016
- Out with the Old in with the New: A Comparison of Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Platform presentation at the University of Oklahoma’s Infectious Disease Conference Audience: Pharmacists, Infectious Diseases Physicians, Infectious Diseases Fellows March 2016
- Determination of medication possession ratio thresholds for viral suppression in HIV-infected patients Presented research poster at ASHP Midyear Clinical Meeting Audience: Pharmacists, Pharmacy Residents, Pharmacy Students December 2015
- Impact of various antiretroviral therapies on the incidence of immune reconstitution inflammatory syndrome in treatment-naïve HIV patients Platform presentation at Alcalde Southwest Leadership Conference April 2015
- Impact of various antiretroviral therapies on the incidence of immune reconstitution inflammatory syndrome in treatment-naïve HIV patients Presented research poster at ASHP Midyear Clinical Meeting Audience: Pharmacists, Pharmacy Residents, Pharmacy Students December 2014
- Proper utilization of botulinum toxin in an institutional setting Presented research poster at ASHP Midyear Clinical Meeting Audience: Pharmacists, Pharmacy Students, College of Science and Technology Faculty December 2013
- Agovi AM, Thompson CT, Craten KJ, Fasanmi EO, Pan M, Ojha RP, Thompson EL. Patient and clinic staff perspectives of the implementation of long-acting injectable antiretroviral therapy program in an urban safety-net health system. Implementation Science Communications. 2024. Aug 29;5(1):93.
- Pan M, Agovi AM, Anikpo IO, Fasanmi EO, Thompson EL, Reeves JM, Thompson CT, Johnson ME, Golub V, Ojha RP. Effect of 2018 American College of Cardiology/American Heart Association Guideline Change on Statin Prescription for People Living with HIV. Preventative Medicine Reports. 2023 Mar 16;33:102175
- Nkwocha CN, Carter PS, Blair S, Blackwell JM, Fasanmi EO. Understanding the effect of direct-acting antiviral therapy on weight in patients with chronic hepatitis C. Antiviral Therapy. 2022 Dec;27(6).
- Agovi AM, Anikpo I, Cvitanovich MJ, Fasanmi EO, Ojha RP, Marcus JL. Brief Report: HIV Pre-exposure Prophylaxis Prescribing in an Urban Safety-Net Health System. JAIDS. 2021 Nov 1;88(3):e17-e21.
- Stewart RA, MacDonald BR, Chu TC, Moore JD, Fasanmi EO, Ojha RP. Ledipasvir/Sofosbuvir Effectively Treats Hepatitis C Virus Infections in an Underserved Population. Digestive Diseases and Sciences. 2018;63(12):3233-3240.
- Ojha RP, MacDonald BR, Chu TC, Fasanmi EO, Moore JD, Stewart RA. Comparative Effectiveness of 8- and 12-week ledipasvir/sofosbuvir regimens for HCV infection. Antiviral Therapy. 2018;23 (7):585-592.
- Barnes K, Fasanmi E, Iwuorie O, Simon P, Hylick E. Cocaine Induced Cardiomyopathy. US Pharmacist. 2015; 40(2): HS11-15